Michelino De Laurentiis

机构：Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Scuola Superiore Meridionale, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0001-9009-1572

发表论文 615 篇 · 总被引 20420 次 · h-index 68

代表论文

• Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer (2025 · European Journal of Cancer · 被引 1)
• Natural Products as Modulators of the DNA Damage Response and Oncogenic Signaling in Breast Cancer Therapy (2026 · International Journal of Molecular Sciences)
• Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer (2026 · Clinical Cancer Research)
• Impact of trop-2 expression on the efficacy of trop-2–targeted antibody–drug conjugates in metastatic breast cancer: a systematic review and meta-analysis (2026 · JNCI Journal of the National Cancer Institute)
• Real-world evidence of sacituzumab govitecan in metastatic triple-negative breast cancer: an updated multicenter analysis (2026 · ESMO Open)
• Efficacy and safety of first-line systemic therapies for patients with metastatic triple negative breast cancer ineligible for anti-PD-(L)1 inhibitors in clinical practice: a systematic review and network meta-analysis (2026 · Research Square)